Literature DB >> 33420956

Pan-coronavirus fusion inhibitors as the hope for today and tomorrow.

Xinling Wang1, Shuai Xia1, Yun Zhu2, Lu Lu3, Shibo Jiang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33420956      PMCID： PMC7796682          DOI： 10.1007/s13238-020-00806-7

Source DB:  PubMed          Journal:  Protein Cell        ISSN： 1674-800X            Impact factor:   14.870


× No keyword cloud information.
  2 in total

1.  More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults.

Authors:  Ana B Gorini da Veiga; Letícia G Martins; Irina Riediger; Alix Mazetto; Maria do Carmo Debur; Tatiana S Gregianini
Journal:  J Med Virol       Date:  2020-07-28       Impact factor: 2.327

2.  Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.

Authors:  Hannah Kleine-Weber; Mahmoud Tarek Elzayat; Lingshu Wang; Barney S Graham; Marcel A Müller; Christian Drosten; Stefan Pöhlmann; Markus Hoffmann
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103
  2 in total
  17 in total

1.  SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites.

Authors:  Li Yang; Te Liang; Lane M Pierson; Hongye Wang; Jesse K Fletcher; Shu Wang; Duran Bao; Lili Zhang; Zhen Huang; Wenshu Zheng; Xiaomei Zhang; Heewon Park; Yuwen Li; James E Robinson; Amy K Feehan; Christopher J Lyon; Jing Cao; Lisa A Morici; Chenzhong Li; Chad J Roy; Xiaobo Yu; Tony Hu
Journal:  Research (Wash D C)       Date:  2022-07-09

Review 2.  Peptide-based Fusion Inhibitors for Preventing the Six-helix Bundle Formation of Class I Fusion Proteins: HIV and Beyond.

Authors:  Ajit Monteiro; Karl O A Yu; Mark D Hicar
Journal:  Curr HIV Res       Date:  2021       Impact factor: 1.341

Review 3.  Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks.

Authors:  Miao Cao; Xiaojie Su; Shibo Jiang
Journal:  Stem Cell Reports       Date:  2021-03-09       Impact factor: 7.765

Review 4.  A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.

Authors:  Medha Karnik; Narasimha M Beeraka; Chinnappa A Uthaiah; Suma M Nataraj; Anjali Devi S Bettadapura; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Mol Neurobiol       Date:  2021-06-05       Impact factor: 5.590

5.  Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.

Authors:  Shuai Xia; Qiaoshuai Lan; Yun Zhu; Chao Wang; Wei Xu; Zhenghong Yuan; Youhua Xie; Fei Sun; Shibo Jiang; Lu Lu; Yutang Li; Lijue Wang; Fanke Jiao; Jie Zhou; Chen Hua; Qian Wang; Xia Cai; Yang Wu; Jie Gao; Huan Liu; Ge Sun; Jan Münch; Frank Kirchhoff
Journal:  Signal Transduct Target Ther       Date:  2021-07-29

Review 6.  Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19.

Authors:  Can-Rong Wu; Wan-Chao Yin; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2022-01-20       Impact factor: 7.169

7.  A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.

Authors:  Lixiao Xing; Xinfeng Xu; Wei Xu; Zezhong Liu; Xin Shen; Jie Zhou; Ling Xu; Jing Pu; Chan Yang; Yuan Huang; Lu Lu; Shibo Jiang; Shuwen Liu
Journal:  Viruses       Date:  2022-03-13       Impact factor: 5.048

Review 8.  SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies.

Authors:  Ahmed M Almehdi; Ghalia Khoder; Aminah S Alchakee; Azizeh T Alsayyid; Nadin H Sarg; Sameh S M Soliman
Journal:  Infection       Date:  2021-08-02       Impact factor: 3.553

Review 9.  Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses.

Authors:  Xue Li; Liying Zhang; Si Chen; Hongsheng Ouyang; Linzhu Ren
Journal:  Microorganisms       Date:  2021-07-10

Review 10.  SARS-CoV-2 Antiviral Therapy.

Authors:  Kaiming Tao; Philip L Tzou; Janin Nouhin; Hector Bonilla; Prasanna Jagannathan; Robert W Shafer
Journal:  Clin Microbiol Rev       Date:  2021-07-28       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.